Sample results
Wilms' tumor is a rare type of kidney cancer that primarily affects children between ages 3 and 4. It is caused by genetic mutations that lead to overexpression of the IGF-2 gene, resulting in uncontrolled cell growth in the kidney. The IGF-2 blood test is the most important test for identifying the genetic markers associated with this pediatric kidney cancer.
Wilms' tumor is caused by genetic mutations that occur during fetal kidney development, leading to abnormal cell growth in kidney tissue. The most common genetic change involves overexpression of the IGF-2 gene, which produces insulin-like growth factor 2, a protein that promotes cell multiplication. In some cases, Wilms' tumor is associated with genetic syndromes like WAGR syndrome, Denys-Drash syndrome, or Beckwith-Wiedemann syndrome, though most cases occur spontaneously without an inherited genetic condition.
The IGF-2 blood test is the most important genetic marker test for Wilms' tumor because it detects elevated insulin-like growth factor 2 levels that result from overexpression of the IGF-2 gene, which is strongly linked to tumor development. While imaging studies like ultrasound, CT scans, and MRI are essential for diagnosing and staging the tumor, the IGF-2 test provides valuable information about the biological characteristics and genetic factors driving the cancer. This test helps healthcare providers understand the tumor's molecular profile and can guide treatment decisions by identifying patients with specific genetic patterns associated with Wilms' tumor.
You should get tested if your child has a swollen or enlarged abdomen, a hard mass you can feel in the belly area, blood in the urine, fever without infection, abdominal pain, or high blood pressure. Children with genetic syndromes like WAGR, Denys-Drash, or Beckwith-Wiedemann syndrome should undergo regular screening since they have a higher risk of developing Wilms' tumor. Testing is also important if there is a family history of kidney cancer or if your child shows unexplained weight loss, loss of appetite, or persistent fatigue combined with abdominal symptoms.
What this means
Your IGF-2 levels are slightly below the optimal range. While this alone isn't definitive, it may contribute to slower growth patterns or reduced cellular growth signals, especially when considered alongside other growth markers like IGF-1.
Recommended actions
Ensure adequate protein intake from quality sources like lean meats, fish, eggs, and dairy
Prioritize 8-10 hours of quality sleep per night, as growth factors are released during deep sleep
Work with your healthcare provider to evaluate IGF-1 and growth hormone levels for a complete assessment
Consider retesting in 3-6 months to monitor trends and treatment response
Not overhyped or overpriced. Just comprehensive blood testing made simple and for everyone.
Sample results
Your 24/7 Personal Lab Guide
Quick questions: